Recent

% | $
Quotes you view appear here for quick access.

OCATA THERAPEUTICS, INC. Message Board

freddyaophelps 572 posts  |  Last Activity: Mar 27, 2015 9:40 AM Member since: Apr 18, 2013
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • Reply to

    keep_investing 26,500 career posts!

    by freddyaophelps Jan 15, 2015 9:46 AM
    freddyaophelps freddyaophelps Mar 27, 2015 9:40 AM Flag

    Get the confetti ready! The unimaginable 27,500 milestone is going to be shattered today!
    keep_investing
    27496 posts

    You are witnessing history people! keepee is the Cal Ripken Jr. of bashchimping! In an era where chimps delete all their posts every few days it is refreshing to see one who knows what he is and freely gives interviews...

    keep_investing • Nov 20, 2014 4:12 PM
    Freddy, one reason we bashers work so hard...

  • Reply to

    Freddy, Get To Work !

    by rainmanshere Mar 19, 2015 9:37 AM
    freddyaophelps freddyaophelps Mar 26, 2015 12:00 PM Flag

    I remember the day you spammed the ACTCD board with a raymondbabbit alias then posted under your rainman alias a minute later.

    Three Bashchimps Disliked This Post, drizzleboy remembers it to!
    Bwaaaahahahaaahaha

  • freddyaophelps freddyaophelps Mar 26, 2015 10:00 AM Flag

    “Ocata can now take advantage of induced and embryonic pluripotent stem cells to produce commercially viable human tissue for transplantation."

    It's coming keepee and all you bashchimps know it, why else would you post 200 times a day?
    : )

  • Reply to

    Freddy, Get To Work !

    by rainmanshere Mar 19, 2015 9:37 AM
    freddyaophelps freddyaophelps Mar 26, 2015 8:49 AM Flag

    How you doing drizzle? Did you start another yahoo account or lose a spam contract? I remember the day you spammed the ACTCD board with a raymondbabbit alias then posted under your rainman alias a minute later, Bwaaahahahaha, you posting chimps do have a sense of humor.

    : )

  • Reply to

    Why do the bashers work so diligently here?

    by freddyaophelps Mar 17, 2015 9:22 AM
    freddyaophelps freddyaophelps Mar 26, 2015 8:34 AM Flag

    Ocata Therapeutics Receives Regulatory Guidance from European Medicines Agency

  • Reply to

    WHY DO PUMPTARDS WORK SO DILIGENTLY HERE

    by am.udaddy Mar 25, 2015 3:12 PM
    freddyaophelps freddyaophelps Mar 25, 2015 5:53 PM Flag

    chimpdaddy you found the cap button again! keepee was cap"n (get the joke cap'n, captain) it this morning, chimpland was turned upside down !

  • Reply to

    Why do the bashers work so diligently here?

    by freddyaophelps Mar 17, 2015 9:22 AM
    freddyaophelps freddyaophelps Mar 25, 2015 4:11 PM Flag

    drizzleboy are you the "mother" of all these new little bashchimps born today? I haven't added them up but looks like you had quints, that's a long hard day of chimping, is that why you're so testy? Do you still get paid on up days?

    : )

  • Reply to

    Isnt this bankrupt technically?

    by jumpin_juniper Mar 25, 2015 1:58 PM
    freddyaophelps freddyaophelps Mar 25, 2015 3:36 PM Flag

    keepee would you explain again why you "bashers work so hard" and tell us how many is "we"?

    keep_investing • Nov 20, 2014 4:12 PM
    Freddy, one reason we bashers work so hard...
    ------------------------------------------------------------

    Honesty from a basher, what happened to you that day keepee, guilty conscience?

  • Reply to

    Why do the bashers work so diligently here?

    by freddyaophelps Mar 17, 2015 9:22 AM
    freddyaophelps freddyaophelps Mar 25, 2015 2:30 PM Flag

    Ocata Announces Proof-of-Concept Results in Restoring Vision and Prevention of Blindness

  • freddyaophelps freddyaophelps Mar 25, 2015 2:20 PM Flag

    “We have had a strong leadership role in this area,” said Robert Lanza, M.D., Chief Scientific Officer of Ocata. “Ocata has extensive experience and patent rights in generating both ocular and non-ocular cell types from human iPSCs. We have painstakingly and patiently evaluated many different iPSC technologies and selected the Allele technology only after we were satisfied and confident that this represented the best of all approaches and could permit us to generate transplantable tissues that would be potentially safe in human patients. In our hands, the iPSCs we are generating are comparable to our embryonic stem cells in those features required for use in potential human therapies.”

  • freddyaophelps freddyaophelps Mar 25, 2015 2:15 PM Flag

    bwwaaahahahahaa, how many aliases have you made in my honor?!! You must think I'm a real dangerous man!

  • Reply to

    This company and stock is Broken

    by nogoldengoosehere Mar 25, 2015 2:03 PM
    freddyaophelps freddyaophelps Mar 25, 2015 2:08 PM Flag

    No I think a spam contract got broken, poor sob is going to have trouble making trailer rent again, MDBX down another 5% today, nothing working for the poor bashchimp.

    : )

  • I suspect he lost a spam contract to have room for that many new aliases.

  • Reply to

    Who In their right mind would buy this?

    by itsinthe.water Mar 25, 2015 1:49 PM
    freddyaophelps freddyaophelps Mar 25, 2015 1:53 PM Flag

    We are witnessing the uncontrolled birthing of bashchimps! He's either lost a spam contract or started another yahoo account to have that many open alias slots.

    itsinthe.water
    2 posts
    Member since: Mar 25, 2015

    jim.dandy30
    1 post
    Member since: Mar 25, 2015

  • freddyaophelps freddyaophelps Mar 25, 2015 1:44 PM Flag

    jim.dandy30
    1 post |
    Member since: Mar 25, 2015

    Happy Birthday bashchimp!

  • freddyaophelps freddyaophelps Mar 25, 2015 1:19 PM Flag

    Does anyone need proof that Jack is right?

    keep_investing • Nov 20, 2014 4:12 PM
    Freddy, one reason we bashers work so hard...

    One sentence directly from the bashchimps mouth says it all so well.

  • Reply to

    Press Release : )

    by freddyaophelps Mar 24, 2015 9:07 AM
    freddyaophelps freddyaophelps Mar 25, 2015 10:47 AM Flag

    Ocata Announces Proof-of-Concept Results in Restoring Vision and Prevention of Blindness

    Ocata can now take advantage of induced and embryonic pluripotent stem cells to produce commercially viable human tissue for transplantation. We recently confirmed proof of concept in creating photoreceptors capable of preventing blindness and restoring vision in established animal models. Data from these studies will be published later this year.”

    : )

  • Reply to

    Press Release : )

    by freddyaophelps Mar 24, 2015 9:07 AM
    freddyaophelps freddyaophelps Mar 24, 2015 6:40 PM Flag

    MARLBOROUGH, Mass.-- Ocata Therapeutics, Inc. (“Ocata” or “the Company”; NASDAQ: OCAT), a leader in the field of Regenerative Ophthalmology™, today announced that it has entered into a definitive agreement with Allele Biotechnology & Pharmaceuticals, Inc. of San Diego, CA (“Allele”) to access Allele’s proprietary technology for generating human induced pluripotent stem cells (“iPSCs”).

    "This agreement with Allele is part of our strategy to broaden our technology platform and increase our leadership in regenerative ophthalmology,” said Paul Wotton Ph.D., President and CEO of Ocata. “Ocata can now take advantage of induced and embryonic pluripotent stem cells to produce commercially viable human tissue for transplantation. We recently confirmed proof of concept in creating photoreceptors capable of preventing blindness and restoring vision in established animal models. Data from these studies will be published later this year.”

    Since Dr. Yamanaka discovered how to generate iPSCs in 2007 there has been tremendous enthusiasm about the potential to use these pluripotent cells to develop commercially viable therapies. Despite many efforts to develop iPSC derived therapies in the same scalable and reliable way as embryonic stem cells, many of those efforts have been unsuccessful due to issues relating to the growth capacity, differentiation potentials and epigenetic properties of iPSCs. The “footprint-free” reprogramming technology developed by Allele potentially offers a reliable and scalable process for producing iPSCs with superior properties and is a major step for translation of iPSC technology to practical clinical use. These iPSCs can potentially be used to manufacture millions of treatment doses as off-the-shelf therapies for any patient.

    “We have had a strong leadership role in this area,” said Robert Lanza, M.D., Chief Scientific Officer of Ocata. “Ocata has extensive experience and patent rights in generating both ocular and non-ocular cell types from human iPSCs. We have painstakingly and patiently evaluated many different iPSC technologies and selected the Allele technology only after we were satisfied and confident that this represented the best of all approaches and could permit us to generate transplantable tissues that would be potentially safe in human patients. In our hands, the iPSCs we are generating are comparable to our embryonic stem cells in those features required for use in potential human therapies.”

    “It is particularly rewarding to us that Ocata, a company whose understanding of the science and regulatory requirements in this space is unparalleled, has selected the iPSC technology developed at Allele for application in its own pipeline,” said Jiwu Wang Ph.D., President and CEO of Allele. “It only serves to confirm our belief that our iPSC platform is a solution to what otherwise have been unresolved issues associated with the maturation of iPSCs to a fully functional state. The ability to predictably derive stable iPSC lines without using any viral element or foreign DNA enables both fundamental scientific research and clinical applications, which has been the mission of Allele Biotechnology from its inception.”

  • Reply to

    Q2 2015: Partnership of non-core assets

    by freddyaophelps Mar 3, 2015 4:59 PM
    freddyaophelps freddyaophelps Mar 24, 2015 6:16 PM Flag

    Odd how all the bashchimp aliases revert to the same nonsense when they get upset.
    Back to CCTR, you never owned it? You just randomly pick a stock, go to their board and say....buy?

    keep_investing • Feb 13, 2015 10:40 AM Flag
    Anyway just looking at the price history of CCTR is mind boggling, to say the very least...
    So buy yourself 1M shares...

  • Reply to

    Q2 2015: Partnership of non-core assets

    by freddyaophelps Mar 3, 2015 4:59 PM
    freddyaophelps freddyaophelps Mar 24, 2015 5:35 PM Flag

    No chimp, I'm doing fine, like I told your rainman alias this just another step for OCAT. How YOU doing on your CCTR junk? Got to be hard making any money there when only $40 worth traded today, why did you delete your CCTR posts

    : )

ACTC
6.97+0.17(+2.50%)Nov 13 3:59 PMEST